Patient-centered Outcomes with Concomitant Use of Proton Pump Inhibitors and Other Drugs-Reference-Cited by-同舟云学术

Patient-centered Outcomes with Concomitant Use of Proton Pump Inhibitors and Other Drugs

Published:2017-02 Issue:2 Volume:39 Page:404-427.e36
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Shamliyan Tatyana A.,Middleton Maria,Borst Clarissa

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference139 articles.

1. Medscape. 100 Best-Selling, Most Prescribed Branded Drugs. May 6, 2016. http://www.medscape.com/viewarticle/844317_print. Accessed February 6, 2017.

2. Canadian Agency for Drugs and Technologies in Health. Proton Pump Inhibitors and the Risk of Clostridium difficile Infection. Current Practice Report. 2015. https://www.cadth.ca/sites/default/files/pdf/PPI_current_practice_report.pdf. Accessed October 2016.

3. Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period;Haastrup;Aliment Pharmacol Ther,2016

4. Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study;Pottegård;Therap Adv Gastroenterol,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating Medication Challenges: A Strategic Approach to Cardiovascular Health at a Government Hospital;International Journal of Pharmacology;2024-08-01

2. Proton pump inhibitors stabilize the expression of PD‐L1 on cell membrane depending on the phosphorylation of GSK3β;Cancer Medicine;2024-05

3. Key Considerations From a Health Authority Perspective When Proton Pump Inhibitors Are Used to Treat Gastroesophageal Reflux Disease (GERD) and Their Implications;Cureus;2022-11-26

4. POTENTIAL DRUG-DRUG INTERACTIONS IDENTIFIED AS DRUG-RELATED PROBLEMS IN THE TREATMENT OF HOSPITALIZED PATIENTS WITH GASTRITIS AND/OR DUODENITIS OR PEPTIC ULCER DISEASE IN LUBLIN (POLAND) – AN OBSERVATIONAL STUDY;Acta Poloniae Pharmaceutica - Drug Research;2021-01-15

5. Antitumor pharmacotherapy of colorectal cancer in kidney transplant recipients;Therapeutic Advances in Medical Oncology;2019-01